Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
1,706
+624
+58% +$104K 0.04% 91
2026
Q1
$227K Buy
+1,082
New +$272K 0.04% 85
2024
Q3
Sell
-93,187
Closed -$18.8M 127
2024
Q2
$18.8M Buy
93,187
+23,426
+34% +$4.22M 3.78% 2
2024
Q1
$12M Buy
69,761
+20,373
+41% +$3.8M 2.44% 11
2023
Q4
$10.7M Buy
+49,388
New +$8.47M 2.4% 8

Other funds holding PODD

Beck Bode LLC's PODD Position: Q2 2026 in Review

Beck Bode LLC increased its Insulet (PODD) stake by 58% in Q2 2026, buying an estimated $104K and bringing the position to 1,706 shares worth $260K. The position accounts for 0.04% of the portfolio, ranked #91.

Beck Bode LLC first reported a position in PODD in Q4 2023 and has held it in 5 quarters since. The position peaked at $18.8M in Q2 2024. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Beck Bode LLC held 1,706 shares of Insulet worth $260K as of Q2 2026.
  • Beck Bode LLC bought 624 Insulet shares in Q2 2026, an estimated $104K.
  • Insulet made up 0.04% of Beck Bode LLC's portfolio in Q2 2026, its #91 holding.
  • Beck Bode LLC first reported a position in Insulet in Q4 2023 and has held it in 5 quarters since.
  • Beck Bode LLC's Insulet position peaked at $18.8M in Q2 2024.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Beck Bode LLC's 13F filing for Q2 2026, filed 13 Aug 2026.